Downregulation of MicroRNA-320a Inhibits Proliferation and Induces Apoptosis of Retinoblastoma Cells Via Targeting TUSC3

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2020 Sep 16

PMID 32934674

Citations 11

Authors

Li Kong

Yang Sun

Maosheng Chen

Yan Dai

Zhen Liu

Affiliations

Soon will be listed here.

Abstract

MicroRNA (miR)-320a is specific to vertebrates and has been indicated to serve a role in a number of cancer types, such as gastric, colorectal, pancreatic and ovarian cancer. miR-320a has been reported to be expressed at high levels in retinoblastoma tissues; however its role and mechanism of function in retinoblastoma remain to be elucidated. The aim of the present study was to investigate the role of miR-320a in retinoblastoma cells and the underlying mechanisms. The expression of miR-320a in retinoblastoma cell lines Y79 and WERI-Rb-1, and normal human retinal pigment epithelial cell line ARPE-19 was examined via reverse transcription-quantitative PCR (RT-qPCR). TargetScan bioinformatics analysis and dual-luciferase reporter assay were used to predict and reveal the target gene of miR-320a. Target gene expression was detected via RT-qPCR in retinoblastoma cell lines and ARPE-19 cells. Subsequently, gain- or loss-of-function experiments for miR-320a and tumor suppressor candidate 3 (TUSC3) were performed to study the role of miR-320a/TUSC3 in retinoblastoma cells. Cell viability and apoptosis were assessed via MTT and flow cytometry analysis, respectively. Compared with ARPE-19 cells, miR-320a was prominently expressed in retinoblastoma cell lines. TUSC3 was predicted to be a target gene of miR-320a. Compared with ARPE-19 cells, the expression of TUSC3 in retinoblastoma cell lines was reduced. The results of MTT and flow cytometry analysis revealed that overexpression of TUSC3 reduced the viability of retinoblastoma cells and induced apoptosis. Additional analysis indicated that miR-320a inhibitor enhanced the expression of the target gene TUSC3, thereby inhibiting retinoblastoma cell viability and inducing apoptosis. The effects of miR-320a inhibitor on retinoblastoma cells were inhibited by TUSC3-short hairpin RNA. miR-320a regulated the viability and apoptosis of retinoblastoma cells via targeting TUSC3. Therefore, the present study provided a reference for investigating a potential target for the clinical treatment of retinoblastoma.

Citing Articles

MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little Heroes.

Zamani Sani M, Mirzaei M, Mota A, Mohammadian J, Beilankouhi E, Rahmati M Biochem Genet. 2025; .

PMID: 39862293 DOI: 10.1007/s10528-024-10976-2.

MiR-320a upregulation contributes to the effectiveness of pemetrexed by inhibiting the growth and invasion of human lung cancer cell line (Calu-6).

Alvanegh A, Arpanaei A, Esmaeili Gouvarchin Ghaleh H, Mohammad Ganji S Mol Biol Rep. 2024; 51(1):310.

PMID: 38372812 DOI: 10.1007/s11033-024-09207-z.

Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.

Ahangar Davoodi N, Najafi S, Ghale-Noie Z, Piranviseh A, Mollazadeh S, Ahmadi Asouri S Front Cell Dev Biol. 2023; 10:1065837.

PMID: 36619866 PMC: 9816416. DOI: 10.3389/fcell.2022.1065837.

Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma.

Feng Y, Li B, Wang K, Li X, Zhang L, Dong X Front Mol Biosci. 2022; 9:977280.

PMID: 36310592 PMC: 9605205. DOI: 10.3389/fmolb.2022.977280.

pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.

Rozanska A, Cerna-Chavez R, Queen R, Collin J, Zerti D, Dorgau B Stem Cells Transl Med. 2022; 11(4):415-433.

PMID: 35325233 PMC: 9052432. DOI: 10.1093/stcltm/szac008.

References

Gao T, Deng M, Wang Q . MiRNA-320a inhibits trophoblast cell invasion by targeting estrogen-related receptor-gamma. J Obstet Gynaecol Res. 2018; 44(4):756-763. DOI: 10.1111/jog.13560. View

Yong S, Yabin Y, Bing Z, Chuanrong Z, Dianhua G, Jianhuai Z . Reciprocal regulation of DGCR5 and miR-320a affects the cellular malignant phenotype and 5-FU response in pancreatic ductal adenocarcinoma. Oncotarget. 2017; 8(53):90868-90878. PMC: 5710890. DOI: 10.18632/oncotarget.18377. View

Horak P, Tomasich E, Vanhara P, Kratochvilova K, Anees M, Marhold M . TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo. Sci Rep. 2014; 4:3739. PMC: 3894551. DOI: 10.1038/srep03739. View

Wong J, Tucker M, Kleinerman R, Devesa S . Retinoblastoma incidence patterns in the US Surveillance, Epidemiology, and End Results program. JAMA Ophthalmol. 2014; 132(4):478-83. DOI: 10.1001/jamaophthalmol.2013.8001. View

Yu X, Zhang K, Liu F, Zhang J, Zhai C, Cao L . Tumor suppressor candidate 3 as a novel predictor for lymph node metastasis in lung cancer patients. Oncol Lett. 2017; 12(6):5099-5105. PMC: 5228539. DOI: 10.3892/ol.2016.5333. View

Castro-Magdonel B, Orjuela M, Camacho J, Garcia-Chequer A, Cabrera-Munoz L, Sadowinski-Pine S . miRNome landscape analysis reveals a 30 miRNA core in retinoblastoma. BMC Cancer. 2017; 17(1):458. PMC: 5493862. DOI: 10.1186/s12885-017-3421-3. View

Kratochvilova K, Horak P, Esner M, Soucek K, Pils D, Anees M . Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells. Int J Cancer. 2015; 137(6):1330-40. DOI: 10.1002/ijc.29502. View

Ghildiyal M, Zamore P . Small silencing RNAs: an expanding universe. Nat Rev Genet. 2009; 10(2):94-108. PMC: 2724769. DOI: 10.1038/nrg2504. View

Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

10.

Svoronos A, Engelman D, Slack F . OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer. Cancer Res. 2016; 76(13):3666-70. PMC: 4930690. DOI: 10.1158/0008-5472.CAN-16-0359. View

11.

Qin H, Liu J, Du Z, Hu R, Yu Y, Wang Q . Circular RNA hsa_circ_0012673 facilitates lung cancer cell proliferation and invasion via miR-320a/LIMK18521 axis. Eur Rev Med Pharmacol Sci. 2020; 24(4):1841-1852. DOI: 10.26355/eurrev_202002_20362. View

12.

Qadir M, Faheem A . miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer. Crit Rev Eukaryot Gene Expr. 2017; 27(3):197-204. DOI: 10.1615/CritRevEukaryotGeneExpr.2017019494. View

13.

Wang Y, Yang J, Chen P, Song Y, An W, Zhang H . MicroRNA-320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation element-binding protein 1. Cancer Med. 2020; 9(8):2833-2845. PMC: 7163091. DOI: 10.1002/cam4.2919. View

14.

Li Q, Yokoshi M, Okada H, Kawahara Y . The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity. Nat Commun. 2015; 6:6183. DOI: 10.1038/ncomms7183. View

15.

Hammond S . An overview of microRNAs. Adv Drug Deliv Rev. 2015; 87:3-14. PMC: 4504744. DOI: 10.1016/j.addr.2015.05.001. View

16.

Chung K, Kim S, Kim S . Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays. J Korean Surg Soc. 2012; 82(5):271-80. PMC: 3341475. DOI: 10.4174/jkss.2012.82.5.271. View

17.

Gu Y, Pei X, Ren Y, Cai K, Guo K, Chen J . Oncogenic function of TUSC3 in non-small cell lung cancer is associated with Hedgehog signalling pathway. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(7):1749-1760. DOI: 10.1016/j.bbadis.2017.05.005. View

18.

Ohno Y, Koyama H, Yoshikawa T, Takenaka D, Seki S, Yui M . Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients. Radiology. 2015; 275(3):849-61. DOI: 10.1148/radiol.14140936. View

19.

Riquelme I, Tapia O, Leal P, Sandoval A, Varga M, Letelier P . miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway. Cell Oncol (Dordr). 2015; 39(1):23-33. PMC: 4751587. DOI: 10.1007/s13402-015-0247-3. View

20.

Yu X, Zhai C, Fan Y, Zhang J, Liang N, Liu F . TUSC3: a novel tumour suppressor gene and its functional implications. J Cell Mol Med. 2017; 21(9):1711-1718. PMC: 5571513. DOI: 10.1111/jcmm.13128. View